Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Aug 6, 2024, after the close
10-Q filed Aug 6, 2024, 37 days after period end · 0001628280-24-035264
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $46.62M | $49.69M | $40.16M | $30.41M |
| Net Income | -$10.43M | -$4.39M | -$702.00K | $2.67M |
| EPS Diluted |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.03 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.